1
|
Hew A, Lloyd M, Rayner G, Matson A, Rychkova M, Ali R, Winton-Brown T, Perucca P, Kwan P, O'Brien TJ, Velakoulis D, Malpas CB, Loi SM. Psychiatric and cognitive characteristics of older adults admitted to a Video-EEG monitoring (VEM) unit. Epilepsy Behav 2021; 120:107987. [PMID: 33979768 DOI: 10.1016/j.yebeh.2021.107987] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2020] [Revised: 03/20/2021] [Accepted: 04/07/2021] [Indexed: 11/08/2022]
Abstract
OBJECTIVE To compare the clinical, psychiatric, and cognitive characteristics of older with younger patients presenting to a video-EEG monitoring (VEM) unit. METHOD This was a retrospective case-control study involving patients admitted for VEM over a two-year period (from April 2018 to April 2020) at two comprehensive epilepsy units. Patients were categorized into an older (≥60 years) and a younger (<60 years) group. Younger patients were individually matched to older adults to form a matched younger group. Diagnosis was determined by a consensus opinion of epileptologists, neurologists, and neuropsychiatrists. The main diagnostic categories were epilepsy, psychogenic nonepileptic seizures (PNES), and 'other' diagnosis (non-diagnostic and other nonepileptic diagnoses). Clinical psychiatric diagnoses were obtained from neuropsychiatric reports. Objective cognitive function was measured with the Neuropsychiatry Unit Cognitive Assessment Tool (NUCOG). Subjective cognitive function was assessed using the Quality of Life in Epilepsy Inventory-89 (QOLIE-89) cognitive subscales. RESULTS Five-hundred and thirty three patients (71 older, 462 younger) aged 16-91 years were admitted to the VEM unit during the study period. There was a diagnosis of focal epilepsy in 55% of the older group and 48% of the younger group, generalized epilepsy in 3% of the older group and 10% of the younger group, and 'other' in 32% of the older group and 19% of the younger group. Ten percent (2 males and 5 females) of the older group were diagnosed with PNES compared to 22% of the younger group (p = 0.016). A depressive disorder was diagnosed in 34% of the older group and 24% of the younger group (p = 0.20). An anxiety disorder was diagnosed in 15% of the older group and 25% of the younger group (p = 0.15). Mild neurocognitive disorder was more common in the older group (34%) compared to the matched younger group (34% vs 3%, p < 0.001). The older group had lower mean NUCOG scores compared to the matched younger group (79.49 vs 87.73, p = <0.001). There was no evidence for a relationship between mean NUCOG score and overall subjective cognitive difficulties for the older group (r = 0.03, p = 0.83). Among older adults, those diagnosed with PNES had more experiences of childhood trauma. Measures of dissociation, depression, or general anxiety did not differ between PNES and non-PNES diagnoses in the older group. CONCLUSION Psychiatric comorbidities are common among older adults admitted for VEM. The psychological impact of epilepsy and risk factors for PNES seen in younger patients are also applicable in the older group. The older group demonstrated more cognitive impairments than the younger group, although these were usually unrecognized by individuals. Older adults admitted to VEM will benefit from psychiatric and neuropsychological input to ensure a comprehensive care approach to evaluation and management.
Collapse
Affiliation(s)
- Anthony Hew
- Department of Neuropsychiatry, The Royal Melbourne Hospital, Parkville, Australia.
| | - Michael Lloyd
- Department of Psychiatry, Alfred Health, Prahran, Australia
| | - Genevieve Rayner
- Melbourne School of Psychological Sciences, The University of Melbourne, Australia; Department of Neurosciences, Alfred Health, Australia; Department of Medicine, Austin Hospital, The University of Melbourne
| | - Alice Matson
- Melbourne School of Psychological Sciences, The University of Melbourne, Australia
| | - Maria Rychkova
- Department of Medicine (RMH), The University of Melbourne, Australia; Department of Neurosciences, Monash University, Australia; Department of Neurology, Alfred Health, Prahran, Australia
| | - Rashida Ali
- Department of Medicine (RMH), The University of Melbourne, Australia; Department of Neurosciences, Monash University, Australia; Department of Neurology, Alfred Health, Prahran, Australia
| | | | - Piero Perucca
- Department of Medicine (RMH), The University of Melbourne, Australia; Department of Neurology, Royal Melbourne Hospital, Parkville, Australia; Department of Neurosciences, Monash University, Australia; Department of Neurology, Alfred Health, Prahran, Australia
| | - Patrick Kwan
- Department of Medicine (RMH), The University of Melbourne, Australia; Department of Neurology, Royal Melbourne Hospital, Parkville, Australia; Department of Neurosciences, Monash University, Australia; Department of Neurology, Alfred Health, Prahran, Australia
| | - Terence J O'Brien
- Department of Medicine (RMH), The University of Melbourne, Australia; Department of Neurology, Royal Melbourne Hospital, Parkville, Australia; Department of Neurosciences, Monash University, Australia; Department of Neurology, Alfred Health, Prahran, Australia
| | - Dennis Velakoulis
- Department of Neuropsychiatry, The Royal Melbourne Hospital, Parkville, Australia; Melbourne Neuropsychiatry Centre, University of Melbourne and NorthWestern Mental Health, Melbourne, VIC, Australia; Department of Psychiatry, University of Melbourne, Australia
| | - Charles B Malpas
- Department of Medicine (RMH), The University of Melbourne, Australia; Department of Neurology, Royal Melbourne Hospital, Parkville, Australia; Melbourne School of Psychological Sciences, The University of Melbourne, Australia
| | - Samantha M Loi
- Department of Medicine (RMH), The University of Melbourne, Australia; Department of Neurology, Royal Melbourne Hospital, Parkville, Australia; Melbourne School of Psychological Sciences, The University of Melbourne, Australia
| |
Collapse
|
3
|
Health anxiety disorders in older adults: conceptualizing complex conditions in late life. Clin Psychol Rev 2013; 33:1096-105. [PMID: 24091001 DOI: 10.1016/j.cpr.2013.08.010] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2013] [Revised: 07/31/2013] [Accepted: 08/05/2013] [Indexed: 11/21/2022]
Abstract
Health anxiety disorders (e.g., hypochondriasis) are prevalent but understudied in older adults. Existing research suggests that severe health anxiety has a late age of onset, perhaps because of comorbidity with physical health conditions that are more likely to occur with aging. Despite being under diagnosed in later life due to a lack of age-appropriate diagnostic criteria, significant positive associations with age suggest that health anxiety disorders are more prevalent in older than younger adults. Preliminary research also highlights the complexity of these disorders in older adults and the potential importance of medical morbidity as a risk factor. This review explores the complexities of health anxiety disorders in later life with a focus on understanding defining features, prevalence rates, correlates, assessment, diagnosis, and treatment. We offer a theoretical model of the development of severe health anxiety among older adults to encourage further research on this important and under-studied topic.
Collapse
|
5
|
Abstract
Somatoform disorders are presentations where physical symptoms worry a patient, there is no organic pathology to explain them, but reassurance fails. They represent a murky borderland between medicine and psychiatry and understanding has not been helped by the plethora of terms used in this area. A typical scenario would be a 68-year-old woman who was recently widowed complaining to a general practitioner of headache, trouble sleeping, tiredness and muscle pain. Blood tests are negative but the patient says “there must be something wrong”. Faced with uncertainty, clinicians may easily fall back on a fruitless path of investigations and referrals. There is plenty of knowledge regarding somatoform disorders among younger people (who have fewer physical illnesses), but much less regarding older people. This article focuses on what is known about these disorders in older people, a practical way forward and what may develop in the future.
Collapse
Affiliation(s)
- Bart Sheehan
- Health Sciences Research Institute, Medical School Building, University of Warwick, Coventry CV4 7AL, UK
| |
Collapse
|